Leadership Overview
GenScript has 8 executives leading key functions including finance, operations, and business development.
Driven by innovation, GenScript provides comprehensive life science services and products, fostering global research advancements through its integrated platforms and commitment to scientific progress.
Driven by innovation, GenScript provides comprehensive life science services and products, fostering global research advancements through its integrated platforms and commitment to scientific progress.
Leadership Roles at GenScript
Patrick Liu - Acting Chief Executive Officer, ProBio
Patrick Liu, the Acting Chief Executive Officer, ProBio at GenScript, spearheads the strategic direction and operational execution for the ProBio division. This critical role involves driving innovation and market penetration for GenScript's industrial synthetic products platform. Liu oversees business development, product lifecycle management, and cross-functional team leadership to achieve ambitious growth targets. By fostering strategic partnerships and optimizing production processes, Patrick Liu ensures the ProBio division remains at the forefront of industrial biotechnology. Liu's leadership is instrumental in expanding GenScript's market reach and solidifying its position as a key provider of synthetic biological solutions.
Phil Zhou - Chief Financial Officer
Phil Zhou, the Chief Financial Officer at GenScript, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and financial reporting, Zhou ensures robust financial health across the organization. This leadership role involves managing capital allocation and investor relations to support GenScript's global expansion and platform development. By optimizing financial strategies, Phil Zhou directly contributes to the company's sustained growth and market leadership in life sciences services. Ultimately, Zhou secures long-term financial stability and drives shareholder value through meticulous financial oversight.
Josie Zhou - Interim Chief Financial Officer & Vice President, Finance
Josie Zhou, the Interim Chief Financial Officer & Vice President, Finance at GenScript, manages immediate financial directives and oversees the finance department's daily operations. This dual role ensures continuity in fiscal management while supporting strategic financial initiatives. Zhou's responsibilities include financial analysis, cash flow management, and the implementation of financial controls critical for a global biotech company. By collaborating with other executive leaders, Josie Zhou aligns financial activities with the company's overarching business objectives, particularly in supporting the CDMO and cell therapy platforms. Zhou's financial acumen is vital for navigating market dynamics and ensuring operational efficiency.
Patrick L. - President, Biosciences Group
Patrick L., the President, Biosciences Group at GenScript, directs the strategic vision and operational oversight for the company's core life sciences services and products platform. This leadership position involves managing a global team dedicated to providing comprehensive solutions to researchers worldwide. Patrick L. oversees the development and delivery of cutting-edge research tools and services, ensuring alignment with market needs and scientific advancements. By fostering collaboration and driving operational excellence, Patrick L. enhances GenScript's ability to support groundbreaking discoveries. The President, Biosciences Group ensures the platform's continued innovation and market leadership in serving the global research community.
Janice Jin - Division President, , Life Science Group, Genscript (APAC)
Janice Jin, the Division President, Life Science Group, Genscript (APAC) at GenScript, leads the strategic expansion and operational management of the Life Science Group across the Asia-Pacific region. Jin's focus is on driving market share and delivering GenScript's comprehensive life science services and products to researchers throughout APAC. This role involves cultivating key relationships with academic institutions and industry partners to foster collaboration and accelerate scientific progress. By tailoring GenScript's offerings to regional demands, Janice Jin ensures localized success and strengthens the company's global presence. Jin's leadership is pivotal in advancing research capabilities within the APAC market.
Ray Chen - President, Life Science Group
Ray Chen, the President, Life Science Group at GenScript, drives the strategic growth and operational efficiency of the company's flagship life science services and products division. Chen oversees the development and deployment of innovative solutions that empower global research communities. This leadership position involves managing product portfolios, enhancing customer engagement, and ensuring the highest standards of service delivery. By fostering a culture of continuous improvement, Ray Chen strengthens GenScript's position as a premier provider of research tools and services. Chen's strategic direction is crucial for expanding the group's impact and supporting scientific breakthroughs worldwide.
Luquan Wang - Executive Director and President
Luquan Wang, the Executive Director and President at GenScript, provides high-level strategic guidance and executive leadership across key organizational functions. This broad mandate involves overseeing critical business initiatives and ensuring alignment with GenScript's long-term vision. Wang's responsibilities encompass driving operational excellence, fostering innovation, and strengthening the company's global market position. By championing strategic partnerships and optimizing resource allocation, Luquan Wang contributes significantly to GenScript's sustained growth and leadership in the biotech sector. Wang's executive oversight is vital for navigating complex industry landscapes and achieving corporate objectives.
Sally Wang - President
Sally Wang, the President at GenScript, directs overarching strategic initiatives and operational frameworks that define the company's market approach. This executive role involves guiding multiple divisions toward achieving synergistic growth and maintaining GenScript's leadership in life sciences services and products. Wang focuses on enhancing the company's integrated platforms, including CDMO and cell therapy, to meet evolving global research demands. By fostering a culture of innovation and operational rigor, Sally Wang ensures GenScript remains at the forefront of scientific advancement. Wang's leadership is critical for driving business development and solidifying the company's competitive advantage.
Explore Leadership Teams in Business Services
PAREXEL International Corporation, a biopharmaceutical outsourcing services company, provides clinical research and logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting Services (PC), and PAREXEL Informatics (PI). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management, and biostatistical analysis, epidemiology and health economics/outcomes research, clinical supply and drug logistics, pharmacovigilance, commercialization, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. The PC segment provides technical expertise and advice in various areas, such as drug development, regulatory affairs, product pricing and reimbursement, commercialization, and strategic compliance; and market and product development, and targeted communications services to support product launch, as well as offers solutions to address client issues associated with product development, registration, and commercialization. The PI segment provides information technology solutions comprising ClinPhone randomization and trial supply management solutions, medical imaging services, IMPACT clinical trial management systems, LIQUENT InSight regulatory information management software and professional services, DataLabs electronic data capture systems, Web-based portals, systems integration services, electronic patient reported outcomes, and patient diary applications, as well as centralized assessment services for patient technology solutions. PAREXEL International Corporation was founded in 1983 and is headquartered in Waltham,...
Company Leadership AF
AS
FB
Worldwide Clinical Trials is a global, mid-sized CRO that provides top-performing, preclinical, and Phase I-IV clinical development services to the biotechnology and pharmaceutical industries. Founded in 1986, our full-service clinical experience ranges from early phase and bioanalytical sciences through late phase studies, post approval, and real-world evidence. Major therapeutic areas of focus include Cardiovascular, Metabolic, Neuroscience, Oncology, and Rare Diseases.
Company Leadership DG
JF
KG
Founded in 1984, SCS Global Services provides third-party environmental and sustainability certification, auditing, testing, and standards development services to clients in the United States and internationally. SCS is located in Emeryville, California.
Company Leadership KG
Embrapa (Brazilian Agricultural Research Corporation) is a Brazilian public research institution headquartered in Brasilia, Brazil. Founded in 1973 and linked to the Ministry of Agriculture, Embrapa conducts agricultural research and development to improve productivity, sustainability, and competitiveness of Brazilian agriculture. The organization operates a network of research centers across Brazil.
Company Leadership FO
SM
RC
Frequently Asked Questions Regarding GenScript Top Executives and Leadership Team
